Stock Mumak

Stock Profile

Moderna, Inc.

Moderna is one of the leading biotechnology companies in the field of mRNA technology. A strong research pipeline and the development of new vaccines and therapeutics offer long-term growth potential.

Latest Portfolio Updates

Weekly Update

Weekly Market Overview – June 29–July 5, 2026

The healthcare sector remains in the lead, while technology and defense stocks are regaining strength. Positive impulses for the UMBRELLA
Next Update
Weekly Update

Weekly Market Overview – June 22-28, 2026

The UMBRELLA Strategy increased its focus on healthcare stocks and biotechnology. Technology showed a mixed performance, while defense stocks came
Next Update
Weekly Update

Weekly Market Overview – June 15-21, 2026

The UMBRELLA Strategy is divesting from energy stocks and further expanding its engagement in the healthcare and biotechnology sector.
Next Update
Weekly Update

Weekly Market Overview – June 8-14, 2026

AI and healthcare innovation are shaping the markets. The UMBRELLA Strategy increases its focus on quality companies and reduces cyclical
Next Update